Interestingly, mRNA expression of osteokines osteocalcin, sclerostin, and Rankl were altered in bone tissue of hypothyroid mice, but not mice treated with zoledronate, underlining a greater impact of hypothyroidism on osteoblast/osteocyte physiology than anti-resorptive treatment. Here, SOST is linked to hypothyroidism.